GRI Bio GRI
NASDAQ GRI
$1.45 +0.02 (+1.40%)
At close: Oct 23, 2026 · 4:00 PM EDT

GRI Bio (GRI) Short-term Investments (2021 - 2022)

Updated

GRI Bio's Short-term Investments came in at $419,000 for Q3 2022, down 87.1% from $3.25 million a year earlier and down 76.0% from the prior quarter.

Analysis

GRI Bio (GRI) Short-term Investments (2021 - 2022) Analysis & Trends

At the end of FY2021, GRI Bio's Short-term Investments was $3.81 million.

  • Business Quant data shows GRI's Short-term Investments at $1.75 million (Q2 2022), $2.63 million (Q1 2022) and $3.81 million (Q4 2021) in the three quarters before Q3 2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,137.66 Bn 1,106.24 Bn 19.71 Bn
2 Johnson & Johnson 636.13 Bn 556.00 Bn 17.30 Bn
3 AbbVie 505.28 Bn 478.39 Bn 12.70 Bn
4 Merck 358.10 Bn 312.48 Bn 12.21 Bn
5 Novartis Ag 292.59 Bn 256.58 Bn 11.24 Bn
6 Astrazeneca 265.81 Bn 239.50 Bn 12.86 Bn
7 Amgen 237.53 Bn 192.93 Bn 7.24 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn
9 Pfizer 171.17 Bn 117.82 Bn 10.94 Bn
10 GRI Bio 2.63 Mn -31.65 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2022 419,000.00
Jun 30, 2022 1.75 Mn
Mar 31, 2022 2.63 Mn
Dec 31, 2021 3.81 Mn
Sep 30, 2021 3.25 Mn
API Access

GRI Bio Short-term Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=short-term-investments&ticker=GRI&period=max&api_key=YOUR_API_KEY